Provided by Tiger Trade Technology Pte. Ltd.

Streamex Corp.

1.06
-0.0250-2.31%
Volume:544.66K
Turnover:576.89K
Market Cap:103.10M
PE:-0.11
High:1.13
Open:1.07
Low:1.04
Close:1.08
52wk High:14.11
52wk Low:0.4901
Shares:97.72M
Float Shares:88.17M
Volume Ratio:0.56
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.6500
EPS(LYR):-0.7487
ROE:-701.65%
ROA:-47.17%
PB:0.77
PE(LYR):-1.41

Loading ...

Company Profile

Company Name:
Streamex Corp.
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
5
Office Location:
2431 Aloma Avenue,Suite 243,Winter Park,Florida,United States
Zip Code:
32792
Fax:
203 429 5044
Introduction:
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Directors

Name
Position
Karl Henry McPhie
Chief Executive Officer and Director
Morgan Lekstrom
Director and Interim Executive Chairman
Anthony Marciano
Director
Donald Browne
Director
Kevin Gopaul
Director
Shawn Matthews
Director

Shareholders

Name
Position
Karl Henry McPhie
Chief Executive Officer and Director
Christine M. Plummer
Chief Financial Officer
Mitchell Williams
Chief Investment Officer
Morgan Lekstrom
Director and Interim Executive Chairman